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Monoclonal antibody (MAb) 12F5 reacted with 35 Escherichia coli O26 isolates and cross-reacted with 1 of
365 non-E. coli O26 isolates. MAb 15C4 reacted with 30 E. coli O111 strains and 8 Salmonella O35 strains
(possessing identical O antigen) but not with 362 other bacterial strains. Lipopolysaccharide immunoblots
confirmed MAb O-antigen specificity.
Escherichia coli O26 and O111 are classic enteropathogenic
and emergent enterohemorrhagic E. coli (EHEC) serotypes.
Among the 13 enteropathogenic serogroups, E. coli O26 and
O111 are epidemiologically predominant and major causes of
pediatric diarrhea, especially in developing countries (22, 29).
E. coli O111 caused 28% of the 50 U.S. infantile diarrhea
outbreaks from 1934 to 1987 (33). Over the past 20 years, Shiga
toxin-producing O26 and O111 emerged worldwide as the clin-
ically most important non-O157 EHEC serotypes and were
linked with sporadic cases and outbreaks of human disease,
including hemorrhagic colitis and hemolytic-uremic syndrome
(HUS) (8, 9, 28). Several EHEC O26- and O111-caused out-
breaks have occurred in Europe and Australia, and 25% of
North American HUS cases may be attributable to non-O157
EHEC (13). In the United States, EHEC O111:NM caused a
family cluster of diarrhea and HUS (3), and EHEC O111:H8
caused a gastroenteritis outbreak affecting more than 50 per-
sons (1).
Pathogenic E. coli O26 and O111 are typically identified by
agglutination, using absorbed polyclonal antibodies (PAb)
against lipopolysaccharide (LPS) O antigen generated by im-
munizing rabbits with E. coli reference strains (22, 26). How-
ever, absorbed anti-E. coli O26 PAb may cross-react with E.
coli possessing O antigens 4, 13, 25, 32, 100, and 102 (26) and
with Pseudomonas aeruginosa O12 (34). Although no E. coli O
antigens cross-react with absorbed anti-E. coli O111 PAb (26),
this PAb strongly agglutinates Salmonella O35 isolates (12, 24)
because of the identical chemical structure of the E. coli O111
and Salmonella O35 O antigens (4, 14, 25). Monoclonal anti-
bodies (MAb) reactive with E. coli O26 (15, 27) and O111 (2,
5–7, 21, 23) have been reported but were not characterized for
diagnostic sensitivity and specificity. The public-health impor-
tance and prevalence of pathogenic E. coli O26 and O111 in
animals, humans, and foods are probably underestimated due
to the lack of available specific serotyping reagents and be-
cause most clinical laboratories do not routinely serotype fecal
E. coli isolates (30). We generated MAb against E. coli O26
and O111 in order to have accurate serotyping reagents for use
in planned epidemiologic surveys of non-O157 EHEC occur-
rence in livestock.
MAb were produced from splenocytes of BALB/c mice im-
munized with E. coli O26:H11 (ECRC DEC 10A) or O111:NM
(ECRC 95.0122) whole-bacterium antigen. Immunization, hy-
bridoma and ascites production, and MAb screening and char-
acterization protocols were previously described (10, 11). MAb
were isotyped with a commercial kit (Zymed Laboratories,
Inc., South San Francisco, Calif.). One anti-O26 MAb (12F5)
and one anti-O111 MAb (15C4) were generated and charac-
terized. MAb diagnostic sensitivity and specificity were esti-
mated by enzyme-linked immunosorbent assay (ELISA) reac-
tivity with whole-bacterium lysates from 400 gram-negative
bacterial strains: 35 E. coli O26 strains, 30 E. coli O111 strains,
26 non-E. coli O26 strains reported to react with anti-O26 PAb
(E. coli O4 [n 5 14], O13, O25 [n 5 6], O32, O100, and O102;
P. aeruginosa O12 [n 5 2]), 225 other E. coli strains of various
O and H serotypes, 57 Salmonella serovars (including O35 [n 5
8]), and 27 other gram-negative bacterial strains. For ELISA,
bacterial-antigen-coated plates were sequentially incubated
with MAb (diluted ascites fluid), horseradish peroxidase
(HRP)-conjugated antibody against mouse immunoglobulin G
(IgG) plus mouse IgM (anti-mouse IgG1IgM), and 2,29-azino-
di-[3-ethylbenzthiazoline sulfonate] solution (ABTS peroxi-
dase substrate) (10). ELISA optical density was measured at
dual wavelengths of 405 and 490 nm (OD405/490); and OD405/
490 of .0.200 was considered positive. Dot box plots (16) of
MAb ELISA OD405/490 values for bacterial-antigen subsets
were generated (Prism 3.0; Graph Pad Software Inc., San Di-
ego, Calif.), and MAb diagnostic-sensitivity and -specificity
point estimates with exact binomial 95% confidence intervals
(CI) were calculated (Epi Info 6.0; Centers for Disease Control
and Prevention, Atlanta, Ga.). Sensitivity was defined as the
number of MAb ELISA-positive isolates per the total number
of isolates tested possessing the target (O111 or O26) antigen.
Specificity was defined as the number of MAb ELISA-nonre-
active isolates per the total number of isolates tested that did
not possess the target antigen.
MAb 12F5 (IgM isotype) reacted strongly by ELISA with 35
E. coli O26 isolates (sensitivity, 100%; 95% CI of 90.0 to 100)
and cross-reacted with 1 of 369 non-E. coli O26 isolates (spec-
ificity, 99.73%; 95% CI of 98.5 to 99.99) (Fig. 1). The cross-
reactive strain, E. coli O4:NM (CDC3377-85), was derived
from a sporadic hemorrhagic-colitis case (32) and was subse-
quently retyped by the E. coli Reference Center (ECRC),
Pennsylvania State University, University Park, as O negative:
NM; the original O4 antigen was apparently lost on passage
since its 1983 isolation. MAb 12F5 was later found to cross-
react with bovine E. coli O-negative:NM field isolates (J. Keen,
unpublished data). While the E. coli O26 O-antigen structure
is known (20), the nature of the MAb-defined O-antigen
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epitope common to E. coli O26 and E. coli O-negative:NM
isolates is unknown. Importantly, MAb 12F5 did not react by
ELISA with any bacteria that cross-react with anti-O26 PAb by
agglutination.
MAb 15C4 (IgG3 isotype) reacted strongly by ELISA with
30 E. coli O111 strains (sensitivity, 100%; 95% CI of 88.4 to
100) and 8 Salmonella O35 isolates (Fig. 2). MAb interaction
with Salmonella O35 represents true antibody-antigen reactiv-
ity, not cross-reactivity, since the E. coli O111 and Salmonella
O35 O antigens are identical (14). MAb 15C4 did not react
with 317 non-E. coli O111 or 49 Salmonella non-O35 isolates
(specificity, 100%; 95% CI of 99.0 to 100).
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis
(18), followed by Western immunoblotting (31) using semi-
purified LPS (17, 19) and whole-bacterium lysates from E. coli
O26 and O111 and non-E. coli O26 and O111 as antigens, con-
firmed MAb O-antigen specificity. Reactive bands from gels
transferred onto polyvinylidene difluoride membranes and in-
cubated with MAb were revealed with HRP-conjugated rabbit
anti-mouse IgG1IgM and diaminobenzidine substrate (10).
FIG. 1. Dot box plots of ELISA reactivities of 343 whole-bacterium lysates with anti-E. coli O26 MAb 12F5. ELISA plates coated with whole-bacterium antigens
were incubated sequentially with MAb 12F5 (ascites fluid, 1:7,000), anti-mouse IgG1IgM-HRP, and ABTS solution. A MAb ELISA OD405/490 of .0.200 was
considered positive. Dots represent means of duplicate OD values. The bottom and top edges of the superimposed box plots are the 25th and 75th distribution
percentiles, respectively; the central horizontal line is the median (50th percentile), and the central vertical lines extend from the box as far as the data extend (range).
CRX, non-E. coli O26 bacteria known to cross-react with anti-E. coli O26 PAb. Data for MAb ELISA reactivity with 57 Salmonella isolates are not shown.
FIG. 2. Dot box plots of ELISA reactivities of 351 whole-bacterium lysates with anti-E. coli O111 MAb 15C4. ELISA plates coated with whole-bacterium antigens
were incubated sequentially with MAb 15C4 (ascites fluid; 1:64,000), anti-mouse IgG1IgM-HRP, and ABTS solution. OD values represent means of duplicate wells.
For dot box plot interpretation, see the legend for Fig. 1. Data for MAb ELISA reactivity with 49 non-O35 Salmonella isolates are not shown.
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The ladder pattern characteristic of LPS was observed on sil-
ver-stained gels and MAb-incubated membranes (Fig. 3). MAb
12F5 reacted with LPS from E. coli O26:H11 and O4:NM
CDC3377-85 but not with LPS from five other bacterial strains.
MAb 15C4 reacted only with E. coli O111 and Salmonella en-
terica serovar Adelaide O35 LPS. Similar immunoblots re-
sulted when whole-bacterium lysates were used in place of LPS
(data not shown).
In summary, we produced and characterized MAb against
E. coli O26 and O111 that were sensitive and specific as as-
sessed by ELISA against 400 target and nontarget isolates.
Immunoblots against purified LPS confirmed MAb O-chain
specificity. These MAb have potential use as immunodiagnos-
tic reagents whether used alone or in combination with other
phenotypic or genotypic markers.
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